ArticleEuropean journal of pain (London, England)2025
Assessment of Mechanical Detection Thresholds in Healthy Participants and Patients With Neuropathy: A Comparison of OptiHair2 and Aesthesiometer II.
Article in European journal of pain (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Assessment of Mechanical Detection Thresholds in Healthy Participants and Patients With Neuropathy: A Comparison of OptiHair2 and Aesthesiometer II.European journal of pain (London, England) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMechanical detection thresholds (MDTs) are used to assess somatosensory function but can only be evaluated considering the individual sex, age and tested body region. The German Research Network on Neuropathic Pain (DFNS) provides reference values for OptiHair2, a sensitive and expensive glass filament, while nylon filaments such as the Aesthesiometer II are more durable and affordable. In this study, we compare both devices regarding their use for MDT assessment in a variety of participants, thus intending to achieve a higher range for MDT.
methodsMDTs of healthy children (< 18y), healthy adults (> 18y) and adult patients with symptoms of suspected polyneuropathy were determined using OptiHair2 glass filaments (0.25-512mN) and Aesthesiometer II nylon filaments (0.63-235.36mN), using the method of limits according to the DFNS protocol. Testing was performed on the cheek, hand and foot in healthy participants; patients were tested on the hand and foot only. Concordance Correlation Coefficient (CCC), Pearson correlation and linear regression analysis were performed.
resultsThe study included 55 participants (33 female, 30 healthy adults aged 22-62 years, 10 healthy children aged 9-15 years, 15 patients aged 35-86 years). There was a relevant concordance of MDTs between Aesthesiometer II and OptiHair2 at the hand (CCC children = 0.14, healthy adults = 0.56, patients = 0.66) and foot (CCC children = 0.24, healthy adults = 0.66, patients = 0.70) but not on the cheek (CCC children = 0.00, healthy adults = 0.01).
conclusionsThe Aesthesiometer II can be a viable replacement for OptiHair2 in less densely innervated areas like the feet, when screening for polyneuropathy, especially in bedside settings due to its robust materials. However, its stronger lowest force (0.63 vs. 0.25 mN) implicates poorer sensitivity for MDT assessments when testing highly innervated areas like the face. SIGNIFICANCE STATEMENT: This study suggests the use of robust Aesthesiometer II nylon filaments as an alternative to the more fragile OptiHair2 glass filaments for MDT assessments. While we find that only OptiHair2 seems to be suitable for more densely innervated areas like the face, Aesthesiometer II's durability and cost-efficiency make it a useful bedside tool, especially for assessing suspected polyneuropathy in less densely innervated areas like the feet.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.